Prestige Consumer Healthcare (PBH) Earnings (2010 - 2026)
Prestige Consumer Healthcare (PBH) earnings from Jun 30, 2010 to Mar 31, 2026. The TTM Prestige Consumer Healthcare (PBH) earnings is $190M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Prestige Consumer Healthcare (PBH) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -11.32% |
| 5 Years TTM | +2.94% |
| 10 Years TTM | +6.66% |
| All Time TTM | +12.30% |
Annual Earnings change of Prestige Consumer Healthcare (PBH)
| Year | Earnings | Change |
|---|---|---|
| 2026 | $190M | -11.33% |
| 2025 | $215M | +2.52% |
| 2024 | $209M | -354.33% |
| 2023 | -$82M | -140.08% |
| 2022 | $205M | +24.71% |
| 2021 | $165M | +15.74% |
| 2020 | $142M | -497.43% |
| 2019 | -$36M | -193.79% |
| 2018 | $38M | -87.87% |
| 2017 | $315M | +894.91% |
| 2016 | $32M | +13.00% |
| 2015 | $28M | +31.52% |
| 2014 | $21M | +580.19% |
| 2013 | $3.13M | -74.47% |
| 2012 | $12M | +28.92% |
| 2011 | $9.51M | -70.39% |
| 2010 | $32M | N/A |
Comparison Prestige Consumer Healthcare (PBH) five years earnings CAGR with competitors
Prestige Consumer Healthcare (PBH) five years earnings CAGR is 2.93%.
| Ticker | Name | five years Earnings CAGR | Upside |
|---|---|---|---|
| AMPH | Amphastar Pharmaceuticals Inc | 99.69% | +3297.81% |
| INCR | INC Research Holdings Inc | 64.08% | +2084.19% |
| TLRY | Tilray Brands Inc | 57.78% | +1869.14% |
| PRGO | Perrigo Company plc | 51.08% | +1641.04% |
| RGC | Regencell Bioscience Holdings Ltd | 34.56% | +1078.03% |
| CPIX | Cumberland Pharmaceuticals Inc | 28.38% | +867.32% |
| UTHR | United Therapeutics Corp | 26.00% | +786.11% |
| SBFM | Sunshine Biopharma Inc | 23.97% | +716.87% |
| RDY | Dr. Reddy`s Laboratories Ltd | 21.66% | +638.24% |
| AYTU | Aytu BioPharma Inc | 21.24% | +624.06% |
| PAHC | Phibro Animal Health Corp - Class A | 17.29% | +489.23% |
| BCRX | Biocryst Pharmaceuticals Inc | 16.93% | +477.09% |
| SNOA | Sonoma Pharmaceuticals Inc | 11.83% | +303.12% |
| NBIX | Neurocrine Biosciences Inc | 10.71% | +265.04% |
| CRDL | Cardiol Therapeutics Inc - Class A | 10.44% | +255.69% |
| ZTS | Zoetis Inc - Class A | 8.54% | +190.95% |
| KMDA | Kamada Ltd | 6.87% | +134.16% |
| AQST | Aquestive Therapeutics Inc | 5.03% | +71.32% |
| PRFX | PRF Technologies Ltd | 4.38% | +49.30% |
| SXTC | China SXT Pharmaceuticals Inc | 3.75% | +27.82% |
| CPHI | China Pharma Holdings Inc | 3.58% | +22.06% |
| BHC | Bausch Health Companies Inc | 3.48% | +18.67% |